GOVX

GeoVax Labs, Inc. (NASDAQ:GOVX) is a clinical-stage biotechnology company founded in 1988 and headquartered in Smyrna, Georgia. The company went public in September 2020 and specializes in developing human vaccines and immunotherapies against infectious diseases and cancers using its proprietary modified vaccinia ankara virus-like particle (MVA-VLP) vaccine platform. GeoVax has established strategic partnerships with prestigious institutions including the National Institutes of Health, Centers for Disease Control and Prevention, U.S. Department of Defense, Emory University, University of Pittsburgh, and the Burnet Institute. The company has evolved from its early research focus to become a clinical-stage developer with multiple vaccine candidates in various phases of development.